Cyanobacterial Harmful Algal Blooms: Chapter 1: An Overview of the Interagency, International Symposium on Cyanobacterial Harmful Algal Blooms (ISOC-HAB): Advancing the Scientific Understanding of Freshwater Harmful Algal Blooms

There is growing evidence that the spatial and temporal incidence of harmful algal blooms is increasing, posing potential risks to human health and ecosystem sustainability. Currently there are no US Federal guidelines, Water Quality Criteria and Standards, or regulations concerning the management of harmful algal blooms. Algal blooms in freshwater are predominantly cyanobacteria, some of which produce highly potent cyanotoxins. The US Congress mandated a Scientific Assessment of Freshwater Harmful Algal Blooms in the 2004 reauthorization of the Harmful Algal Blooms and Hypoxia Research and Control Act. To further the scientific understanding of freshwater harmful algal blooms, the US Environmental Protection Agency (EPA) established an interagency committee to organize the Interagency, International Symposium on Cyanobacterial Harmful Algal Blooms (ISOC-HAB). A theoretical framework to define scientific issues and a systems approach to implement the assessment and management of cyanobacterial harmful algal blooms were developed as organizing themes for the symposium. Seven major topic areas and 23 subtopics were addressed in Workgroups and platform sessions during the symposium. The primary charge given to platform presenters was to describe the state of the science in the subtopic areas, whereas the Workgroups were charged with identifying research that could be accomplished in the short- and long-term to reduce scientific uncertainties. The proceedings of the symposium, published in this monograph, are intended to inform policy determinations and the mandated Scientific Assessment by describing the scientific knowledge and areas of uncertainty concerning freshwater harmful algal blooms

Aging and the Environment: A Research Framework

The rapid growth in the number of older Americans has many implications for public health, including the need to better understand the risks posed to older adults by environmental exposures. Biologic capacity declines with normal aging; this may be exacerbated in individuals with pre-existing health conditions. This decline can result in compromised pharmacokinetic and pharmacodynamic responses to environmental exposures encountered in daily activities. In recognition of this issue, the U.S. Environmental Protection Agency (EPA) is developing a research agenda on the environment and older adults. The U.S. EPA proposes to apply an environmental public health paradigm to better understand the relationships between external pollution sources → human exposures → internal dose → early biologic effect → adverse health effects for older adults. The initial challenge will be using information about aging-related changes in exposure, pharmacokinetic, and pharmacodynamic factors to identify susceptible subgroups within the diverse population of older adults. These changes may interact with specific diseases of aging or medications used to treat these conditions. Constructs such as “frailty” may help to capture some of the diversity in the older adult population. Data are needed regarding a) behavior/activity patterns and exposure to the pollutants in the microenvironments of older adults; b) changes in absorption, distribution, metabolism, and excretion with aging; c) alterations in reserve capacity that alter the body’s ability to compensate for the effects of environmental exposures; and d) strategies for effective communication of risk and risk reduction methods to older individuals and communities. This article summarizes the U.S. EPA’s development of a framework to address and prioritize the exposure, health effects, and risk communications concerns for the U.S. EPA’s evolving research program on older adults as a susceptible subpopulation

The Use of Biomonitoring Data in Exposure and Human Health Risk Assessments

Biomonitoring uses analytic methods that permit the accurate measurement of low levels of environmental chemicals in human tissues. However, depending on the intended use, biomonitoring, like all exposure tools, may not be a stand-alone exposure assessment tool for some of its environmental public health uses. Although biomonitoring data demonstrate that many environmental chemicals are absorbed in human tissues, uncertainty exists regarding if and at what concentrations many of these chemicals cause adverse health outcomes. Moreover, without exposure pathway information, it is difficult to relate biomonitoring results to sources and routes of exposure and develop effective health risk management strategies. In September 2004, the Health and Environmental Sciences Institute, U.S. Environmental Protection Agency, Centers for Disease Control and Prevention, Agency for Toxic Substances and Disease Registry, and International Council of Chemical Associations co-sponsored the International Biomonitoring Workshop, which explored the processes and information needed for placing biomonitoring data into perspective for risk assessment purposes, with special emphasis on integrating biomarker measurements of exposure, internal dose, and potential health outcome. Scientists from international governments, academia, and industry recommended criteria for applying biomonitoring data for various uses. Six case studies, which are part of this mini-monograph, were examined: inorganic arsenic, methyl eugenol, organophosphorus pesticides, perfluorooctanesulfonate, phthalates, and polybrominated diphenyl ethers. Based on the workshop and follow-up discussions, this overview article summarizes lessons learned, identifies data gaps, outlines research needs, and offers guidance for designing and conducting biomonitoring studies, as well as interpreting biomonitoring data in the context of risk assessment and risk management